Literature DB >> 25771505

The unique regulation and functions of type III interferons in antiviral immunity.

Charlotte Odendall1, Jonathan C Kagan2.   

Abstract

Type I interferons (IFNs) were long considered to be the sole IFN species produced by virus-infected cells until the discovery of type III IFNs (IFNλs), decades later. Like type I IFNs, type III IFNs are induced by and protect against viral infections, leading to the initial conclusion that the two IFN species are identical in regulation and biological functions. However, the two systems differ in the tissue expression of their receptor, resulting in different roles in vivo. The unique nature of IFNλs has been further demonstrated by recent studies revealing differences in the regulation of type I and III IFN expression, and how these proteins elicit specific cellular responses. This review focuses on the distinctive features of type III IFNs in antiviral innate immunity.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25771505      PMCID: PMC4470718          DOI: 10.1016/j.coviro.2015.02.003

Source DB:  PubMed          Journal:  Curr Opin Virol        ISSN: 1879-6257            Impact factor:   7.090


  44 in total

1.  Type 1 IFN-independent activation of a subset of interferon stimulated genes in West Nile virus Eg101-infected mouse cells.

Authors:  Joanna A Pulit-Penaloza; Svetlana V Scherbik; Margo A Brinton
Journal:  Virology       Date:  2012-02-03       Impact factor: 3.616

2.  Membrane perturbation elicits an IRF3-dependent, interferon-independent antiviral response.

Authors:  Ryan S Noyce; Kathryne Taylor; Marta Ciechonska; Susan E Collins; Roy Duncan; Karen L Mossman
Journal:  J Virol       Date:  2011-08-03       Impact factor: 5.103

3.  Regulation of IFN-λ1 promoter activity (IFN-λ1/IL-29) in human airway epithelial cells.

Authors:  Rachael Siegel; Joyce Eskdale; Grant Gallagher
Journal:  J Immunol       Date:  2011-11-04       Impact factor: 5.422

4.  Role of the p38 MAPK signaling pathway in mediating interleukin-28A-induced migration of UMUC-3 cells.

Authors:  Se-Jung Lee; Wun-Jae Kim; Sung-Kwon Moon
Journal:  Int J Mol Med       Date:  2012-07-16       Impact factor: 4.101

5.  A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus.

Authors:  Ludmila Prokunina-Olsson; Brian Muchmore; Wei Tang; Ruth M Pfeiffer; Heiyoung Park; Harold Dickensheets; Dianna Hergott; Patricia Porter-Gill; Adam Mumy; Indu Kohaar; Sabrina Chen; Nathan Brand; McAnthony Tarway; Luyang Liu; Faruk Sheikh; Jacquie Astemborski; Herbert L Bonkovsky; Brian R Edlin; Charles D Howell; Timothy R Morgan; David L Thomas; Barbara Rehermann; Raymond P Donnelly; Thomas R O'Brien
Journal:  Nat Genet       Date:  2013-01-06       Impact factor: 38.330

6.  Identification of a novel pathway essential for the immediate-early, interferon-independent antiviral response to enveloped virions.

Authors:  Ryan S Noyce; Susan E Collins; Karen L Mossman
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

7.  Mitochondrial-associated endoplasmic reticulum membranes (MAM) form innate immune synapses and are targeted by hepatitis C virus.

Authors:  Stacy M Horner; Helene Minyi Liu; Hae Soo Park; Jessica Briley; Michael Gale
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-15       Impact factor: 11.205

8.  Neurotropic arboviruses induce interferon regulatory factor 3-mediated neuronal responses that are cytoprotective, interferon independent, and inhibited by Western equine encephalitis virus capsid.

Authors:  Daniel C Peltier; Helen M Lazear; Jocelyn R Farmer; Michael S Diamond; David J Miller
Journal:  J Virol       Date:  2012-11-28       Impact factor: 5.103

9.  Respiratory virus-induced EGFR activation suppresses IRF1-dependent interferon λ and antiviral defense in airway epithelium.

Authors:  Iris F Ueki; Gundula Min-Oo; April Kalinowski; Eric Ballon-Landa; Lewis L Lanier; Jay A Nadel; Jonathan L Koff
Journal:  J Exp Med       Date:  2013-09-02       Impact factor: 14.307

10.  siRNA enhances DNA-mediated interferon lambda-1 response through crosstalk between RIG-I and IFI16 signalling pathway.

Authors:  Hongyan Sui; Ming Zhou; Qian Chen; H Clifford Lane; Tomozumi Imamichi
Journal:  Nucleic Acids Res       Date:  2013-09-18       Impact factor: 16.971

View more
  41 in total

Review 1.  Activation and pathogenic manipulation of the sensors of the innate immune system.

Authors:  Charlotte Odendall; Jonathan C Kagan
Journal:  Microbes Infect       Date:  2017-01-14       Impact factor: 2.700

2.  Type I interferons instigate fetal demise after Zika virus infection.

Authors:  Laura J Yockey; Kellie A Jurado; Nitin Arora; Alon Millet; Tasfia Rakib; Kristin M Milano; Andrew K Hastings; Erol Fikrig; Yong Kong; Tamas L Horvath; Scott Weatherbee; Harvey J Kliman; Carolyn B Coyne; Akiko Iwasaki
Journal:  Sci Immunol       Date:  2018-01-05

3.  Mechanisms of Innate Immune Activation by a Hybrid Alphavirus-Rhabdovirus Vaccine Platform.

Authors:  Anthony M Marchese; Carolina Chiale; Safiehkhatoon Moshkani; Michael D Robek
Journal:  J Interferon Cytokine Res       Date:  2019-10-18       Impact factor: 2.607

4.  Interferon Regulatory Factor 1 Protects against Chikungunya Virus-Induced Immunopathology by Restricting Infection in Muscle Cells.

Authors:  Sharmila Nair; Subhajit Poddar; Raeann M Shimak; Michael S Diamond
Journal:  J Virol       Date:  2017-10-27       Impact factor: 5.103

5.  Novel Functions of IFI44L as a Feedback Regulator of Host Antiviral Responses.

Authors:  Marta L DeDiego; Luis Martinez-Sobrido; David J Topham
Journal:  J Virol       Date:  2019-10-15       Impact factor: 5.103

6.  Middle East Respiratory Syndrome Coronavirus Nucleocapsid Protein Suppresses Type I and Type III Interferon Induction by Targeting RIG-I Signaling.

Authors:  Chi-You Chang; Helene Minyi Liu; Ming-Fu Chang; Shin C Chang
Journal:  J Virol       Date:  2020-06-16       Impact factor: 5.103

Review 7.  Early local immune defences in the respiratory tract.

Authors:  Akiko Iwasaki; Ellen F Foxman; Ryan D Molony
Journal:  Nat Rev Immunol       Date:  2016-11-28       Impact factor: 53.106

8.  Dynamic innate immune response determines susceptibility to SARS-CoV-2 infection and early replication kinetics.

Authors:  Nagarjuna R Cheemarla; Timothy A Watkins; Valia T Mihaylova; Bao Wang; Dejian Zhao; Guilin Wang; Marie L Landry; Ellen F Foxman
Journal:  J Exp Med       Date:  2021-06-15       Impact factor: 17.579

Review 9.  Promising Immunotherapies against COVID-19.

Authors:  Haodong Guo; Lili Zhou; Zhenyu Ma; Zhixin Tian; Fangfang Zhou
Journal:  Adv Ther (Weinh)       Date:  2021-05-16

Review 10.  Too young to die? How aging affects cellular innate immune responses to influenza virus and disease severity.

Authors:  Christopher M Harpur; Mélanie A Le Page; Michelle D Tate
Journal:  Virulence       Date:  2021-12       Impact factor: 5.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.